NCT01832402 2023-06-08
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
4 trialsNCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01856114 2020-09-16
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01518140 2013-08-13
BiPAP-Vapotherm RCT
M.D. Anderson Cancer Center
Phase 2 Withdrawn